Gilead Sciences GILD NASDAQ:GILD

Healthcare Active Runners: Express Scripts Holding (NASDAQ:ESRX), Zogenix (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX), Abbott Laboratories (NYSE:ABT)

Express Scripts (NASDAQ:ESRX) announced that it has been recognized by the Ethisphere Institute, an independent center of research promoting best practices in corporate ethics and governance, as a 2014 World’s Most Ethical Company Express Scripts Holding Company (NASDAQ:ESRX) stock performance was -1.19% in last session and finished the day at $76.99. Traded volume was 13,770,673 million shares in the last session and the average volume … Continue reading Healthcare Active Runners: Express Scripts Holding (NASDAQ:ESRX), Zogenix (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX), Abbott Laboratories (NYSE:ABT)

Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Abbott Laboratories (NYSE:ABT), Zogenix Inc. (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX)

Trading in Pfizer Inc. (NYSE:PFE) was halted last week because of pending news. While we see that all the time in smaller biotechs, MannKind will likely be halted next week during an FDA advisory committee meeting. Pfizer Inc. (NYSE:PFE) stock performance was 0.85% in last session and finished the day at $32.18. Traded volume was 62.72million shares in the last session and the average volume … Continue reading Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Abbott Laboratories (NYSE:ABT), Zogenix Inc. (NASDAQ:ZGNX), Boston Scientific (NYSE:BSX)

FB Nasdaq FB Facebook

Healthcare Active Stocks: Peregrine Pharmaceuticals (NASDAQ:PPHM), Merck & Co (NYSE:MRK), Teva Pharmaceutical Industries (NYSE:TEVA), Abbott Laboratories (NYSE:ABT)

Shares of Peregrine Pharmaceuticals (NASDAQ: PPHM ) , a biopharmaceutical company focused on developing monoclonal antibodies to treat cancer, dipped as much as 11% after reporting its third-quarter earnings results. Peregrine Pharmaceuticals (NASDAQ:PPHM) stock performance was -8.05% in last session and finished the day at $2.40. Traded volume was 14.14million shares in the last session and the average volume of the stock remained 4.31million shares. … Continue reading Healthcare Active Stocks: Peregrine Pharmaceuticals (NASDAQ:PPHM), Merck & Co (NYSE:MRK), Teva Pharmaceutical Industries (NYSE:TEVA), Abbott Laboratories (NYSE:ABT)

Healthcare Active Runners: Peregrine Pharmaceuticals (NASDAQ:PPHM), Bristol-Myers Squibb (NYSE:BMY), Abbott Laboratories (NYSE:ABT), Teva Pharmaceutical Industries (NYSE:TEVA)

Peregrine Pharmaceuticals (NASDAQ:PPHM) is scheduled to be releasing its Q314 earnings data on Friday, March 7th. Peregrine Pharmaceuticals (NASDAQ:PPHM) stock performance was 47.64% in last session and finished the day at $2.82. Traded volume was 36.76million shares in the last session and the average volume of the stock remained 3.12million shares. The beta of the stock remained 1.40. Peregrine Pharmaceuticals (NASDAQ:PPHM) insider ownership is 16%. … Continue reading Healthcare Active Runners: Peregrine Pharmaceuticals (NASDAQ:PPHM), Bristol-Myers Squibb (NYSE:BMY), Abbott Laboratories (NYSE:ABT), Teva Pharmaceutical Industries (NYSE:TEVA)

Healthcare ACtive Runners: Teva Pharmaceutical Industries (NYSE:TEVA), Exelixis (NASDAQ:EXEL), Novavax (NASDAQ:NVAX), Abbott Laboratories (NYSE:ABT), Celgene (NASDAQ:CELG)

Just a month ago, Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) snapped up portfolio company, San Mateo, CA-based Labrys Biologics, for $200 million up front and another $625 million in milestones. That deal came less than two years after Labrys was formed, and venBio partner and co-founder Corey Goodman told Xconomy at the time that venBio had contributed $8.5 million of Labrys’ $31 million Series A round plus an … Continue reading Healthcare ACtive Runners: Teva Pharmaceutical Industries (NYSE:TEVA), Exelixis (NASDAQ:EXEL), Novavax (NASDAQ:NVAX), Abbott Laboratories (NYSE:ABT), Celgene (NASDAQ:CELG)

FB Nasdaq FB Facebook

Healthcare Watch List: Arena Pharmaceuticals (NASDAQ:ARNA), Abbott Laboratories (NYSE:ABT), UnitedHealth Group (NYSE:UNH), AstraZeneca (NYSE:AZN)

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported that Eisai Inc. has launched a national television advertising campaign for BELVIQ® (lorcaserin HCl), an FDA-approved prescription treatment for chronic weight management. Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock performance was 0.32% in last session and finished the day at $6.20. Traded volume was 4.92million shares in the last session and the average volume of the stock remained 5.60million shares. The beta … Continue reading Healthcare Watch List: Arena Pharmaceuticals (NASDAQ:ARNA), Abbott Laboratories (NYSE:ABT), UnitedHealth Group (NYSE:UNH), AstraZeneca (NYSE:AZN)